MARKET

RMTI

RMTI

Rockwell Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.680
-0.120
-6.67%
After Hours: 1.710 +0.03 +1.79% 19:16 08/06 EDT
OPEN
1.800
PREV CLOSE
1.800
HIGH
1.800
LOW
1.650
VOLUME
599.00K
TURNOVER
--
52 WEEK HIGH
3.850
52 WEEK LOW
1.306
MARKET CAP
116.04M
P/E (TTM)
-3.1615
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average RMTI stock price target is 10.00 with a high estimate of 11.00 and a low estimate of 9.00.

EPS

RMTI News

More
Rockwell Medical to Host Conference Call and Webcast to Discuss Second Quarter 2020 Financial Results and Recent Operational Highlights
WIXOM, Mich., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today ann
GlobeNewswire · 3d ago
MU, SPG among premarket gainers
Seeking Alpha - Article · 06/30 12:21
Does Rockwell Medical (NASDAQ:RMTI) Have A Healthy Balance Sheet?
Simply Wall St. · 06/17 13:43
Rockwell Medical, Inc. Appoints Dr. Allen R. Nissenson to Board of Directors
WIXOM, Mich., June 10, 2020 -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia.
GlobeNewswire · 06/10 20:30
Hedge Funds Watching Rockwell Medical Inc (RMTI) From Afar
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. I
Insider Monkey · 05/27 16:43
Rockwell Medical files NDS for Triferic AVNU in Canada
Rockwell Medical (NASDAQ:RMTI) has filed a New Drug Submission (“NDS”) with Health Canada for Triferic AVNU (ferric pyrophosphate citrate). The Company see
seekingalpha · 05/26 16:20
Rockwell Medical, Inc. Files New Drug Submission with Health Canada for Marketing Approval of Triferic® AVNU™
WIXOM, Mich., May 26, 2020 -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia.
GlobeNewswire · 05/26 11:00
Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/12 01:54

Industry

Biotechnology & Medical Research
-0.96%
Pharmaceuticals & Medical Research
-0.46%

Hot Stocks

Symbol
Price
%Change

About RMTI

Rockwell Medical, Inc. is a biopharmaceutical company. The Company is targeting end-stage renal disease and chronic kidney disease with products for the treatment of iron deficiency and hemodialysis. The Company is also a manufacturer of hemodialysis concentrates for dialysis providers and distributors. The Company’s renal drug therapy, Triferic, supports disease management initiatives. Triferic is therapy indicated to replace iron and maintain hemoglobin in hemodialysis patients via dialysate during each dialysis treatment. The Company has developed multiple formulations of Triferic: Dialysate Triferic and Intravenous Triferic (I.V. Triferic). Dialysate Triferic is the therapeutic indicated for iron replacement and maintenance of hemoglobin in hemodialysis patients.
More

Webull offers kinds of Rockwell Medical Inc stock information, including NASDAQ:RMTI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RMTI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RMTI stock methods without spending real money on the virtual paper trading platform.